Skip to search boxSkip to navigationSkip to main content

Prevalence of and risk factors for human papillomavirus (HPV) infection among HIV-seronegative men who have sex with men

  • Stephen Goldstone(corresponding author)
    ,
  • Joel M. Palefsky
    ,
  • Anna R. Giuliano
    ,
  • Edson D. Moreira
    ,
  • Carlos Aranda
    ,
  • Heiko Jessen
*Corresponding author for this work
  • Icahn School of Medicine at Mount Sinai
    ,
  • University of California at San Francisco
    ,
  • University of South Florida
    ,
  • Fundação Oswaldo Cruz
    ,
  • Instituto Nacional de Salud Publica
    ,
  • J2: Private Clinic for Infectious Diseases
Scholary Output:
Contribution to journal
Article
Peer-review

Open access

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

Background. We examined the baseline prevalence of penile, scrotal, perineal/perianal, and intra-anal human papillomavirus (HPV) infection in human immunodeficiency virus (HIV)-seronegative men who have sex with men (MSM). Methods. Data were analyzed from 602 MSM aged 16-27 years with ≤5 lifetime sexual partners. Serum samples were tested for antibodies to HPV6/11/16/18. Swab samples were collected separately from several anogenital areas for detection of HPV6/11/16/18/31/33/35/39/45/51/52/56/58/59 DNA. Results. The prevalence of any tested HPV type was 18.5% at the penis, 17.1% at the scrotum, 33.0% at the perineal/ perianal region, 42.4% in the anal canal, and 48.0% at any site. Overall, 415 MSM (69.7%) were negative to HPV 6, 11, 16, and 18 at enrollment by both serology and DNA detection. Men residing in Europe and Latin America had significantly increased risk of HPV infection at external genital sites and the anal canal compared to men from Australia. Tobacco use and greater number of lifetime sexual partners was associated with higher HPV infection prevalence. Conclusions. The prevalence of HPV infection is high among young sexually active MSM, with the anal canal being the most common site of infection. Lifetime number of sexual partners was the most important modifiable risk factor for anogenital HPV infection.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 66-74 (9 pages)

Journal (Volume, Issue Number)

Journal of Infectious Diseases (Volume 203, Issue 1)

Publication milestones

  • Published - 01/01/2011

Publication status

Published - 01/01/2011

ISSN

0022-1899

Publication IDs

  • Scopus: 79851500696
  • PubMed: 21148498

Publication metrics

Metrics

SciVal
citations
121
SciVal
FWCI
4.42
SciVal
Author count
17
SciVal
Paper percentile
97
SciVal
Top percentile
5
Fractional count
1
Fractional count
0.06
Fractional count
16
Fractional count
0.94
Fractional count
1
Fractional count
1
Scopus
citations

PlumX, opens in new tab

Mentions
1
Citation count
160
Captures
180

Funding Details

Potential conflicts of interest: EDM, DGF, ARG, and JMP have received research grants from Merck, either personally or through their institution. DGF has received research grants from GlaxoSmithKline. ARG, SG, DGF, RJH, and EDM have received honoraria from Merck for speaking engagements or board membership. SG, ARG, DGF, JMP, and EDM have received travel reimbursement from Merck related to scientific meetings. CA has an approved, filed, or pending patent related to subject matter discussed in this manuscript. EIOG, EB, RMH, DG, JBM, KLL, and SV are employees of Merck and may own Merck stock and/or stock options. This work was supported by Merck.